Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04296110 · ClinicalTrials.gov registry record · NA
Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD (Study 2)
A NA study, sponsored by Nationwide Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT04296110 is a NA study that was terminated before completion, run by Nationwide Children's Hospital. The registered enrollment target is 48 participants.
The verdict
NCT04296110, a NA study, was terminated before completion, sponsored by Nationwide Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This prospective, randomized, longitudinal, controlled study will enroll pediatric CD patients with inflammatory, non-stricturing, and non-penetrating disease type with mild/quiescent disease based on Pediatric Crohn's Disease Activity Index (PCDAI). Participants will be randomized to receive HRV biofeedback intervention daily for 12 weeks or to music relaxation therapy.
Interventions
- BEHAVIORAL Biofeedback
- OTHER Music Relaxation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2024-08-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04296110
The ClinicalTrials.gov registry entry for NCT04296110 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biofeedback is the first listed.
NCT04296110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04296110 about?
NCT04296110 is a clinical study titled "Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD (Study 2)". This prospective, randomized, longitudinal, controlled study will enroll pediatric CD patients with inflammatory, non-stricturing, and non-penetrating disease type with mild/quiescent disease based on Pediatric Crohn's Disease Activity Index (PCDAI). Participants will be randomized to receive HRV bi...
What is the current status of trial NCT04296110?
This trial is currently terminated. It is a NA study. The enrollment target is 48 participants. The study started on 2020-03-12. Estimated completion is 2024-08-14.
What interventions are being tested in trial NCT04296110?
The interventions under investigation include: Biofeedback (BEHAVIORAL), Music Relaxation Therapy (OTHER).
Who is sponsoring clinical trial NCT04296110?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.